These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30876528)

  • 21. Innovative invasive management without stent implantation guided by optical coherence tomography in acute coronary syndrome.
    Souteyrand G; Viallard L; Combaret N; Pereira B; Clerfond G; Malcles G; Barber-Chamoux N; Prati F; Motreff P
    Arch Cardiovasc Dis; 2018 Nov; 111(11):666-677. PubMed ID: 29934117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with non-ST segment elevation acute coronary syndrome.
    Lee T; Murai T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):905-914. PubMed ID: 28303685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography.
    Kashiwagi M; Tanaka A; Kitabata H; Tsujioka H; Kataiwa H; Komukai K; Tanimoto T; Takemoto K; Takarada S; Kubo T; Hirata K; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1412-9. PubMed ID: 20083077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of coronary plaques and atherosclerosis using optical coherence tomography.
    Shimamura K; Kubo T; Akasaka T
    Expert Rev Cardiovasc Ther; 2021 May; 19(5):379-386. PubMed ID: 33823735
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.
    Johnson TW; Räber L; di Mario C; Bourantas C; Jia H; Mattesini A; Gonzalo N; de la Torre Hernandez JM; Prati F; Koskinas K; Joner M; Radu MD; Erlinge D; Regar E; Kunadian V; Maehara A; Byrne RA; Capodanno D; Akasaka T; Wijns W; Mintz GS; Guagliumi G
    Eur Heart J; 2019 Aug; 40(31):2566-2584. PubMed ID: 31112213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerotic plaque characterization by CT angiography for identification of high-risk coronary artery lesions: a comparison to optical coherence tomography.
    Nakazato R; Otake H; Konishi A; Iwasaki M; Koo BK; Fukuya H; Shinke T; Hirata K; Leipsic J; Berman DS; Min JK
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):373-9. PubMed ID: 25246503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS.
    Miyamoto Y; Okura H; Kume T; Kawamoto T; Neishi Y; Hayashida A; Yamada R; Imai K; Saito K; Yoshida K
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):638-46. PubMed ID: 21679899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT).
    Wykrzykowska JJ; Diletti R; Gutierrez-Chico JL; van Geuns RJ; van der Giessen WJ; Ramcharitar S; Duckers HE; Schultz C; de Feyter P; van der Ent M; Regar E; de Jaegere P; Garcia-Garcia HM; Pawar R; Gonzalo N; Ligthart J; de Schepper J; van den Berg N; Milewski K; Granada JF; Serruys PW
    EuroIntervention; 2012 Dec; 8(8):945-54. PubMed ID: 22669133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological features of non-culprit plaques on optical coherence tomography and integrated backscatter intravascular ultrasound in patients with acute coronary syndromes.
    Maejima N; Hibi K; Saka K; Nakayama N; Matsuzawa Y; Endo M; Iwahashi N; Okuda J; Tsukahara K; Tahara Y; Kosuge M; Ebina T; Umemura S; Kimura K
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):190-7. PubMed ID: 25240169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference of ruptured plaque morphology between asymptomatic coronary artery disease and non-ST elevation acute coronary syndrome patients: an optical coherence tomography study.
    Shimamura K; Ino Y; Kubo T; Nishiguchi T; Tanimoto T; Ozaki Y; Satogami K; Orii M; Shiono Y; Komukai K; Yamano T; Matsuo Y; Kitabata H; Yamaguchi T; Hirata K; Tanaka A; Imanishi T; Akasaka T
    Atherosclerosis; 2014 Aug; 235(2):532-7. PubMed ID: 24953494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease.
    Tazaki R; Tanigawa J; Fujisaka T; Shibata K; Takeda Y; Ishihara T; Hoshiga M; Hanafusa T; Ishizaka N
    Int Heart J; 2016; 57(1):18-24. PubMed ID: 26673442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome).
    Prati F; Romagnoli E; Gatto L; La Manna A; Burzotta F; Limbruno U; Versaci F; Fabbiocchi F; Di Giorgio A; Marco V; Ramazzotti V; Di Vito L; Trani C; Porto I; Boi A; Tavazzi L; Mintz GS
    Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of quantitative bright spots analysis in patients with acute coronary syndrome: an optical coherence tomography study.
    Minami Y; Phipps JE; Hoyt T; Milner TE; Ong DS; Soeda T; Vergallo R; Feldman MD; Jang IK
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1479-87. PubMed ID: 26202158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary plaque ulceration documented at sequential angiography and confirmed by optical coherence tomography in a patient with recurrent acute coronary syndrome.
    Ferlini M; Potenza A; Ferrara E; Ferrario M; Repetto A; Marinoni B; Visconti LO; Bramucci E
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e144-e145. PubMed ID: 25111774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis.
    Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Tuzcu EM; Nissen SE; Nicholls SJ
    Eur J Prev Cardiol; 2015 Oct; 22(10):1331-9. PubMed ID: 26232281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
    Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
    EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study.
    Xie Y; Mintz GS; Yang J; Doi H; Iñiguez A; Dangas GD; Serruys PW; McPherson JA; Wennerblom B; Xu K; Weisz G; Stone GW; Maehara A
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):397-405. PubMed ID: 24631511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.